Key result
Knockdown of lnc000908 cuts cardiac fibrosis and improves function by inhibiting EndMT in rats.
Why the study?
Long non-coding RNAs have emerged as potent regulators of cardiac disease, yet their role in cardiac fibrosis remained only partially understood.
Does lentiviral knockdown of lnc000908 reduce endothelial-mesenchymal transition and improve cardiac fibrosis and cardiac function in rats with isoproterenol-induced cardiac fibrosis?
Does lentiviral knockdown of lnc000908 reduce endothelial-mesenchymal transition and improve cardiac fibrosis and cardiac function in rats with isoproterenol-induced cardiac fibrosis?
Identifies endothelial-enriched lnc000908 as a novel profibrotic regulator in rat hearts that promotes endothelial-mesenchymal transition and cardiac remodelling by suppressing EP4 receptor expression.
Answers are grounded in this paper and cite their sources.
Does not support clinical use; leaves open lnc000908 as a target for cardiac fibrosis pending human studies.
Long non-coding RNAs (lncRNAs) have emerged as potent regulators of cardiac disease; however, the role of lncRNA in cardiac fibrosis remains partially understood. In this study, we identified a cardiac endothelial-enriched lncRNA-lnc000908, which was markedly up-regulated in rats with cardiac fibrosis. In addition, the expression of prostaglandin E2 receptor 4 (EP4) was decreased in cardiac fibrosis. In vivo lnc000908 silencing by lentivirus increased the EP4 level, decreased endothelial-mesenchymal transition (EndMT) and improved cardiac fibrosis and cardiac function. Consistently, the lnc000908 knockdown also up-regulated EP4 and suppressed transforming growth factor-beta (TGF-β)-induced EndMT in cardiac microvascular endothelial cells. In contrast, the lnc000908 overexpression by lentivirus decreased the EP4 level and induced EndMT. Of note, these pro- or anti-EndMT effects were reversed by the EP4 overexpression or the EP4 antagonist AH-23848, respectively. This study demonstrates that lnc000908 is a novel regulator of cardiac fibrosis by modulating the EP4 expression and EndMT.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2019) studied Isoproterenol-induced cardiac fibrosis. Lentivirus-mediated lnc000908 shRNA knockdown (lenti-sh908) vs. Negative control lentivirus (lenti-ctrl) lacking lnc000908 sequence before isoproterenol infusion was evaluated on Myocardial collagen deposition, EndMT marker expression, and echocardiographic cardiac pump function (EF%, FS%, LVEDd, LVESd) at day 21 (p=<0.05). Lentiviral knockdown of lnc000908 down-regulated lnc000908 expression by ~55%, increasing EP4 levels to inhibit EndMT, reduce cardiac fibrosis, and improve cardiac function in rats.
Synapse has enriched 10 related papers. Consider them for comparative context: